-transparent.png){kind=logo}
The μ-opioid receptor is involved in the rewarding effects of not only opioids like morphine but also psychostimulants like amphetamine. This study aimed to investigate associations between subjective response to amphetamine and genetic polymorphisms and haplotypes in the μ-opioid receptor including the exonic variant rs1799971 (Asp40Asn). One hundred and sixty-two Caucasian volunteers participated in three sessions receiving either placebo or d-amphetamine (10 and 20 mg). Associations between levels of self-reported Euphoria, Energy and Stimulation [Addiction Research Center Inventory 49-item questionnaire (ARCI-49)] after d-amphetamine ingestion and polymorphisms in OPRM1 were investigated. The intronic single nucleotide polymorphisms (SNPs) rs510769 and rs2281617 were associated with significantly higher ratings of Euphoria, Energy and Stimulation after 10 mg amphetamine. Feelings of Euphoria, Energy and Stimulation were also found to be associated with a two-SNP haplotype formed with rs1799971 and rs510769 and a three-SNP haplotype formed with rs1918760, rs2281617 and rs1998220. These results support the hypothesis that genetic variability in the μ-opioid receptor gene influences the subjective effects of amphetamine and may suggest new strategies for prevention and treatment of psychostimulant abuse.
A M Dlugos, and
A Hamidovic, and
C Hodgkinson, and
P H Shen, and
D Goldman, and
A A Palmer, and
H de Wit
January 2001,
Biological psychiatry,
A M Dlugos, and
A Hamidovic, and
C Hodgkinson, and
P H Shen, and
D Goldman, and
A A Palmer, and
H de Wit
January 1971,
Clinical pharmacology and therapeutics,
A M Dlugos, and
A Hamidovic, and
C Hodgkinson, and
P H Shen, and
D Goldman, and
A A Palmer, and
H de Wit
February 1997,
Pharmacology, biochemistry, and behavior,
A M Dlugos, and
A Hamidovic, and
C Hodgkinson, and
P H Shen, and
D Goldman, and
A A Palmer, and
H de Wit
October 2009,
Journal of neural transmission (Vienna, Austria : 1996),
A M Dlugos, and
A Hamidovic, and
C Hodgkinson, and
P H Shen, and
D Goldman, and
A A Palmer, and
H de Wit
May 2009,
Biological psychiatry,
A M Dlugos, and
A Hamidovic, and
C Hodgkinson, and
P H Shen, and
D Goldman, and
A A Palmer, and
H de Wit
September 2010,
Clinical pharmacology and therapeutics,
A M Dlugos, and
A Hamidovic, and
C Hodgkinson, and
P H Shen, and
D Goldman, and
A A Palmer, and
H de Wit
October 2005,
Pharmacology, biochemistry, and behavior,
A M Dlugos, and
A Hamidovic, and
C Hodgkinson, and
P H Shen, and
D Goldman, and
A A Palmer, and
H de Wit
January 1985,
Psychopharmacology,
A M Dlugos, and
A Hamidovic, and
C Hodgkinson, and
P H Shen, and
D Goldman, and
A A Palmer, and
H de Wit
October 1988,
The British journal of psychiatry : the journal of mental science,
A M Dlugos, and
A Hamidovic, and
C Hodgkinson, and
P H Shen, and
D Goldman, and
A A Palmer, and
H de Wit
April 2021,
Psychoneuroendocrinology,
